Rhythm Pharmaceuticals (RYTM) Capital Leases (2019 - 2022)
Rhythm Pharmaceuticals (RYTM) posted quarterly Capital Leases of $1.8 million for Q1 2022, down 25.98% year-over-year from $2.4 million in Q1 2021, and down 8.43% quarter-over-quarter from $1.9 million in Q4 2021.
Rhythm Pharmaceuticals (RYTM) Capital Leases (2019 - 2022) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Capital Leases for 4 consecutive years, with $1.8 million the latest figure, recorded in Q1 2022.
- In Q1 2022, Capital Leases fell 25.98% year-over-year to $1.8 million; the TTM figure through Mar 2022 stood at $1.8 million (down 25.98% YoY), while the FY2021 annual figure was $1.9 million, down 23.76% from the prior year.
- Capital Leases eased to $1.8 million in Q1 2022 per RYTM's latest filing, from $1.9 million in the prior quarter.
- Across five years, Capital Leases topped out at $3.4 million in Q1 2019 and bottomed at $1.8 million in Q1 2022.
- Historically, Capital Leases has averaged $2.6 million across 4 years, with a median of $2.6 million in 2020.
- Annual changes were most pronounced in 2020 — Capital Leases decreased 15.1% — and 2022, when it fell 25.98%.
- Rhythm Pharmaceuticals' Capital Leases stood at $3.1 million in 2019, then retreated by 17.34% to $2.6 million in 2020, then slipped by 23.76% to $1.9 million in 2021, then decreased by 8.43% to $1.8 million in 2022.
- Business Quant data shows RYTM's Capital Leases at $1.8 million in Q1 2022, $1.9 million in Q4 2021, and $2.1 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.41 Mn |
| Dec 31, 2020 | 2.55 Mn |
| Sep 30, 2020 | 2.69 Mn |
| Jun 30, 2020 | 2.83 Mn |
| Dec 31, 2019 | 3.09 Mn |
| Sep 30, 2019 | 3.21 Mn |
| Jun 30, 2019 | 3.33 Mn |
| Mar 31, 2019 | 3.45 Mn |